002166 萊茵生物
按盤價 
9.570 +0.870 (+10.000%)
9.570 +0.870 (+10.000%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.271 | 5.212 | 2.663 | 7.246 | 6.474 |
| 總資產報酬率 ROA (%) | 1.407 | 3.380 | 1.817 | 4.634 | 3.689 |
| 投入資產回報率 ROIC (%) | 1.685 | 4.033 | 2.143 | 5.607 | 4.737 | 邊際利潤分析 |
| 銷售毛利率 (%) | 25.001 | 29.325 | 24.415 | 30.799 | 29.804 |
| 營業利潤率 (%) | 8.378 | 12.046 | 7.920 | 18.111 | 14.427 |
| 息稅前利潤/營業總收入 (%) | 10.395 | 13.477 | 9.424 | 17.576 | 16.840 |
| 淨利潤/營業總收入 (%) | 6.225 | 9.435 | 6.583 | 13.442 | 12.455 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.703 | 103.940 | 75.378 | 94.044 | 78.513 |
| 價值變動淨收益/利潤總額(%) | 8.561 | 4.428 | 43.120 | 16.608 | 11.174 |
| 營業外收支淨額/利潤總額(%) | -1.575 | -2.690 | -1.683 | -6.442 | -0.011 | 償債能力分析 |
| 流動比率 (X) | 1.725 | 1.704 | 2.032 | 2.513 | 1.481 |
| 速動比率 (X) | 0.916 | 0.925 | 1.222 | 1.635 | 0.914 |
| 資產負債率 (%) | 36.564 | 36.220 | 30.723 | 30.126 | 41.676 |
| 帶息債務/全部投入資本 (%) | 20.444 | 20.775 | 15.726 | 13.996 | 21.545 |
| 股東權益/帶息債務 (%) | 359.830 | 360.235 | 509.482 | 577.684 | 335.584 |
| 股東權益/負債合計 (%) | 168.785 | 171.853 | 220.366 | 228.331 | 137.582 |
| 利息保障倍數 (X) | 4.843 | 7.718 | 5.763 | 31.330 | 6.976 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 175.765 | 148.472 | 106.842 | 76.234 | 78.175 |
| 存貨周轉天數 (天) | 340.841 | 312.736 | 302.341 | 298.241 | 334.040 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
